Warning: The NCBI web site requires JavaScript to function. more...
Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression.
Trinh AT, Ball BG, Weber E, Gallaher TK, Gluzman-Poltorak Z, Anderson F, Basile LA.
Genet Vaccines Ther. 2009 Dec 30;7:13.
Related citations
Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
Flasshove M, Bardenheuer W, Schneider A, Hirsch G, Bach P, Bury C, Moritz T, Seeber S, Opalka B.
J Cancer Res Clin Oncol. 2000 Jul;126(7):391-9.
Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.
Robbins PB, Yu XJ, Skelton DM, Pepper KA, Wasserman RM, Zhu L, Kohn DB.
J Virol. 1997 Dec;71(12):9466-74.
Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B, Cam H, Schüler T, Indraccolo S, Gladow M, Baum C, Blankenstein T, Uckert W.
Hum Gene Ther. 2003 Aug 10;14(12):1155-68.
A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
Kung SK, An DS, Chen IS.
J Virol. 2000 Apr;74(8):3668-81.
Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors.
Indraccolo S, Minuzzo S, Roccaforte F, Zamarchi R, Habeler W, Stievano L, Tosello V, Klein D, Günzburg WH, Basso G, Chieco-Bianchi L, Amadori A.
Blood. 2001 Dec 15;98(13):3607-17.
Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA, Mullen CA, Morgan RA.
Hum Gene Ther. 1994 Jun;5(6):667-77.
T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC, Marodon G, Pioche-Durieu C, Cosset FL, Klatzmann D.
J Gene Med. 2000 Nov-Dec;2(6):416-25.
Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
Chinnasamy N, Chinnasamy D, Toso JF, Lapointe R, Candotti F, Morgan RA, Hwu P.
Hum Gene Ther. 2000 Sep 1;11(13):1901-9.
Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines.
Hock RA, Miller AD, Osborne WR.
Blood. 1989 Aug 1;74(2):876-81.
Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages.
Auten J, Agarwal M, Chen J, Sutton R, Plavec I.
Hum Gene Ther. 1999 May 20;10(8):1389-99.
Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
Tabotta W, Klein D, Hohenadl C, Salmons B, Günzburg WH.
J Gene Med. 2001 Sep-Oct;3(5):418-26.
Development of improved adenosine deaminase retroviral vectors.
Onodera M, Nelson DM, Yachie A, Jagadeesh GJ, Bunnell BA, Morgan RA, Blaese RM.
J Virol. 1998 Mar;72(3):1769-74.
Locus control region of the human CD2 gene in a lentivirus vector confers position-independent transgene expression.
Kowolik CM, Hu J, Yee JK.
J Virol. 2001 May;75(10):4641-8.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
WPRE-mediated enhancement of gene expression is promoter and cell line specific.
Klein R, Ruttkowski B, Knapp E, Salmons B, Günzburg WH, Hohenadl C.
Gene. 2006 May 10;372:153-61. Epub 2006 Feb 20.
Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector.
Gough PJ, Raines EW.
Blood. 2003 Jan 15;101(2):485-91. Epub 2002 Sep 5.
Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters.
Semple-Rowland SL, Eccles KS, Humberstone EJ.
Mol Vis. 2007 Oct 18;13:2001-11.
Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene.
Marodon G, Mouly E, Blair EJ, Frisen C, Lemoine FM, Klatzmann D.
Blood. 2003 May 1;101(9):3416-23. Epub 2003 Jan 2.
Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M, Duch M, Mygind T, Li H, Ulrich-Vinther M, Modin C, Baatrup A, Lind M, Pedersen FS, Bünger CE.
Adv Exp Med Biol. 2006;585:31-48.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on